Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

2,000 influenza virus genomes now completed and publicly accessible

22.02.2007
Information critical to developing treatments and vaccines

The Influenza Genome Sequencing Project, funded by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), announced today that it has achieved a major milestone. The entire genetic blueprints of more than 2,000 human and avian influenza viruses taken from samples around the world have been completed and the sequence data made available in a public database.

"This information will help scientists understand how influenza viruses evolve and spread," says NIH Director Elias A. Zerhouni, M.D., "and it will aid in the development of new flu vaccines, therapies and diagnostics."

"Scientists around the world can use the sequence data to compare different strains of the virus, identify the genetic factors that determine their virulence, and look for new therapeutic, vaccine and diagnostic targets," says NIAID Director Anthony S. Fauci, M.D.

... more about:
»Genom »Influenza »Virus »flu

The Influenza Genome Sequencing Project, initiated in 2004, has been carried out at the NIAID-funded Microbial Sequencing Center managed by The Institute for Genomic Research (TIGR) of Rockville, Maryland. The project is currently directed by David Spiro, Ph.D., and Claire Fraser, Ph.D., at TIGR and Elodie Ghedin, Ph.D., at the University of Pittsburgh School of Medicine. Recently, growing sequencing capacity has enabled the production rate to increase to more than 200 viral genomes per month. Eclipsing today’s milestone of 2,000 genomes, the microbial sequencing center will continue to rapidly sequence more influenza strains and isolates and will make all the sequence data freely available to the scientific community and the public through GenBank, an Internet-accessible database of genetic sequences maintained by the National Center for Biotechnology Information (NCBI) at NIH’s National Library of Medicine, another major contributor to the project.

Seasonal influenza is a major public health concern in the United States, accounting for approximately 36,000 deaths and 200,000 hospitalizations each year. Globally, influenza results in an estimated 250,000 to half a million deaths annually. Seasonal flu shots are updated every year to target the latest strains in circulation. Developing such vaccines is challenging, however, because the influenza virus is prone to high mutation rates when it replicates, and these mutations can alter the virus enough that vaccines against one strain may not protect against another strain.

An even greater concern is the potential for an influenza pandemic caused by the emergence of a new, highly lethal virus strain that is easily transmitted from person to person. Influenza pandemics have occurred three times in the last century, the most lethal of which was the pandemic of 1918, which caused an estimated 40 to 50 million deaths worldwide.

"A few years ago, only limited genetic information on influenza viruses existed in the public domain, and much of the sequence data was incomplete," says Maria Y. Giovanni, Ph.D., who oversees the NIAID Microbial Sequencing Centers. "The Influenza Genome Sequencing Project has filled that gap by vastly increasing the amount of influenza sequence data and rapidly making it available to the entire scientific community. Subsequently, there has been a marked increase in the number of scientists worldwide depositing influenza genome sequence data into the public domain including scientists at St. Jude Children’s Research Hospital and the Centers for Disease Control and Prevention."

Jason Socrates Bardi | EurekAlert!
Further information:
http://www.niaid.nih.gov

Further reports about: Genom Influenza Virus flu

More articles from Life Sciences:

nachricht What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Simple processing technique could cut cost of organic PV and wearable electronics

06.12.2016 | Materials Sciences

3-D printed kidney phantoms aid nuclear medicine dosing calibration

06.12.2016 | Medical Engineering

Robot on demand: Mobile machining of aircraft components with high precision

06.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>